10 employees
Carolus Therapeutics develops innovative drugs for patients suffering from a host of disorders triggered by acute and chronic inflammation.
2007
$2.3M
from 1 investors over 1 rounds
CAROLUS THERAPEUTICS, INC. raised $2.3M on March 5, 2013
Investors: Square 1 Bank